Skip to main content
. 2013 Feb 6;6:10. doi: 10.1186/1757-2215-6-10

Table 3.

Treatment choice on the basis of platinum sensitivity status (all lines treatment)

  PLD (30 patients) Other therapy (No PLD) 25 patients
Platinum sensitive
9 (30 %)
8 (32%)
Partially-platinum sensitive
10 (33%)
5 (20%)
Platinum refractory 11 (37 %) 12 (48%)